Low-dose combination of losartan, hydrochlorothiazide, and magnetic laser therapy: clinical effectiveness and quality of life impact

Aim. To study losartan effects, as monotherapy and in combination with hydrochlorothiazide (HCH) and magnetic laser therapy (МГТ), on 24-hour blood pressure (BPM) and quality of life (QoP) parameters in patients with mild to moderate arterial hypertension (AH).Material and methods. Bighty-three men...

Full description

Bibliographic Details
Main Authors: Kh. Z. Musieva, A. N. Britov, M. A. Umetov
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2008-08-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1560
_version_ 1827064028685402112
author Kh. Z. Musieva
A. N. Britov
M. A. Umetov
author_facet Kh. Z. Musieva
A. N. Britov
M. A. Umetov
author_sort Kh. Z. Musieva
collection DOAJ
description Aim. To study losartan effects, as monotherapy and in combination with hydrochlorothiazide (HCH) and magnetic laser therapy (МГТ), on 24-hour blood pressure (BPM) and quality of life (QoP) parameters in patients with mild to moderate arterial hypertension (AH).Material and methods. Bighty-three men with mild to moderate AH were examined (mean age 51,4+5,6 years). At baseline and after 4 weeks of the treatment, 24-hour BPM and QoB parameters were measured in all participants.Results. After 4 weeks of the treatment, improved BP circadian rhythm (CR) was observed in all participants, especially in combined therapy groups. In the group of losartan, HCH and МГТ second 24-hour BPM demonstrated normalized BP CR, decreased prevalence of night CR type (from 39% to 25%), and reduced morning BP surge. Bosartan monotherapy, despite its good antihypertensive effect, did not result in BP CR normalization. Synergistic impact of combined pharmaceutical therapy and МГТ was observed in regard to antihypertensive effect and treatment tolerability Maximal changes in various Qor domains were registered among patients with initially low scores (73%); among participants with initially high scores (27%), Qor did not change significantly.Conclusion. Tosartan combination with HCH and МГТ was effective in AH patients, demonstrating not only good antihypertensive effect, but also Qor improvement.
first_indexed 2024-04-10T03:39:32Z
format Article
id doaj.art-75a1299eb4e84885a08d37f03eecf65d
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2025-03-19T22:40:38Z
publishDate 2008-08-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-75a1299eb4e84885a08d37f03eecf65d2024-10-17T12:21:26Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252008-08-017478821277Low-dose combination of losartan, hydrochlorothiazide, and magnetic laser therapy: clinical effectiveness and quality of life impactKh. Z. Musieva0A. N. Britov1M. A. Umetov2Kabardino-Balkar State University. Nal’chikState Research Center for Preventive Medicine. MoscowKabardino-Balkar State University. Nal’chikAim. To study losartan effects, as monotherapy and in combination with hydrochlorothiazide (HCH) and magnetic laser therapy (МГТ), on 24-hour blood pressure (BPM) and quality of life (QoP) parameters in patients with mild to moderate arterial hypertension (AH).Material and methods. Bighty-three men with mild to moderate AH were examined (mean age 51,4+5,6 years). At baseline and after 4 weeks of the treatment, 24-hour BPM and QoB parameters were measured in all participants.Results. After 4 weeks of the treatment, improved BP circadian rhythm (CR) was observed in all participants, especially in combined therapy groups. In the group of losartan, HCH and МГТ second 24-hour BPM demonstrated normalized BP CR, decreased prevalence of night CR type (from 39% to 25%), and reduced morning BP surge. Bosartan monotherapy, despite its good antihypertensive effect, did not result in BP CR normalization. Synergistic impact of combined pharmaceutical therapy and МГТ was observed in regard to antihypertensive effect and treatment tolerability Maximal changes in various Qor domains were registered among patients with initially low scores (73%); among participants with initially high scores (27%), Qor did not change significantly.Conclusion. Tosartan combination with HCH and МГТ was effective in AH patients, demonstrating not only good antihypertensive effect, but also Qor improvement.https://cardiovascular.elpub.ru/jour/article/view/1560arterial hypertensionlosartanmagnetic laser24-hour blood pressure monitoringquality of life
spellingShingle Kh. Z. Musieva
A. N. Britov
M. A. Umetov
Low-dose combination of losartan, hydrochlorothiazide, and magnetic laser therapy: clinical effectiveness and quality of life impact
Кардиоваскулярная терапия и профилактика
arterial hypertension
losartan
magnetic laser
24-hour blood pressure monitoring
quality of life
title Low-dose combination of losartan, hydrochlorothiazide, and magnetic laser therapy: clinical effectiveness and quality of life impact
title_full Low-dose combination of losartan, hydrochlorothiazide, and magnetic laser therapy: clinical effectiveness and quality of life impact
title_fullStr Low-dose combination of losartan, hydrochlorothiazide, and magnetic laser therapy: clinical effectiveness and quality of life impact
title_full_unstemmed Low-dose combination of losartan, hydrochlorothiazide, and magnetic laser therapy: clinical effectiveness and quality of life impact
title_short Low-dose combination of losartan, hydrochlorothiazide, and magnetic laser therapy: clinical effectiveness and quality of life impact
title_sort low dose combination of losartan hydrochlorothiazide and magnetic laser therapy clinical effectiveness and quality of life impact
topic arterial hypertension
losartan
magnetic laser
24-hour blood pressure monitoring
quality of life
url https://cardiovascular.elpub.ru/jour/article/view/1560
work_keys_str_mv AT khzmusieva lowdosecombinationoflosartanhydrochlorothiazideandmagneticlasertherapyclinicaleffectivenessandqualityoflifeimpact
AT anbritov lowdosecombinationoflosartanhydrochlorothiazideandmagneticlasertherapyclinicaleffectivenessandqualityoflifeimpact
AT maumetov lowdosecombinationoflosartanhydrochlorothiazideandmagneticlasertherapyclinicaleffectivenessandqualityoflifeimpact